Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | Amoroso Michael | President and CEO | Sale+OE | 34,799 | $4.17 | $145,111.83 | -15.1% | → |
| 2026-01-21 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 8,854 | $4.03 | $35,681.62 | -16.5% | → |
| 2026-01-21 | Kelly John Alexander | Chief Financial Officer | Sale+OE | 15,213 | $4.03 | $61,308.39 | -12.5% | → |
| 2026-01-21 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 10,200 | $4.03 | $41,106.00 | -8.5% | → |
| 2025-12-16 | Germano Geno J | - | Buy | 3,000 | $4.72 | $14,160.00 | +14.4% | → |
| 2025-12-16 | Frankel Stanley | - | Buy | 2,700 | $4.70 | $12,690.00 | +16.1% | → |
| 2025-12-15 | Brown Melinda | - | Buy | 1,381 | $4.97 | $6,863.57 | +6.3% | → |
| 2025-11-03 | Amoroso Michael | President and CEO | Sale+OE | 3,409 | $6.49 | $22,124.41 | -2.9% | → |
| 2025-11-03 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 665 | $6.49 | $4,315.85 | -2.3% | → |
| 2025-11-03 | Kelly John Alexander | Chief Financial Officer | Sale+OE | 1,303 | $6.49 | $8,456.47 | -1.7% | → |
| 2025-09-26 | Frankel Stanley | Director | Buy | 2,700 | $4.97 | $13,419.00 | +19.2% | → |
| 2025-09-22 | Brown Melinda | Director | Buy | 1,400 | $4.89 | $6,846.00 | +6.8% | → |
| 2025-07-03 | Kelly John Alexander | Chief Financial Officer | Sell | 14,827 | $4.26 | $63,163.02 | -16.8% | → |
| 2025-06-25 | Brown Melinda | - | Buy | 1,682 | $4.14 | $6,963.48 | +8.9% | → |
| 2025-06-25 | Buehler Kevin | - | Buy | 5,076 | $4.16 | $21,116.16 | +22.0% | → |
| 2025-03-26 | Buehler Kevin | - | Buy | 4,523 | $4.67 | $21,122.41 | +51.9% | → |
| 2025-03-26 | Brown Melinda | - | Buy | 1,839 | $4.75 | $8,735.25 | +25.5% | → |
| 2025-03-25 | Germano Geno J | - | Buy | 3,250 | $5.30 | $17,225.00 | +41.6% | → |
| 2025-03-24 | Amoroso Michael | President and CEO | Sale+OE | 964 | $5.56 | $5,359.84 | -0.9% | → |
| 2025-03-04 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 154 | $4.91 | $756.14 | -0.2% | → |
| 2025-03-04 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 272 | $4.91 | $1,335.52 | -1.1% | → |
| 2025-01-22 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 8,928 | $4.79 | $42,765.12 | -26.8% | → |
| 2025-01-22 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 10,287 | $4.79 | $49,274.73 | -10.5% | → |
| 2025-01-21 | Amoroso Michael | President and CEO | Sale+OE | 36,838 | $4.67 | $172,033.46 | -25.6% | → |
| 2024-12-30 | Germano Geno J | - | Buy | 3,605 | $4.49 | $16,186.45 | +85.8% | → |
| 2024-12-27 | Buehler Kevin | - | Buy | 4,320 | $4.88 | $21,081.60 | +98.4% | → |
| 2024-12-27 | Kelly John Alexander | Chief Financial Officer | Buy | 2,113 | $4.75 | $10,036.75 | +5.5% | → |
| 2024-12-26 | Brown Melinda | - | Buy | 3,016 | $4.55 | $13,722.80 | +71.8% | → |
| 2024-11-21 | Kelly John Alexander | Chief Financial Officer | Buy | 3,000 | $6.76 | $20,280.00 | +8.6% | → |
| 2024-11-04 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 588 | $8.19 | $4,815.72 | -6.9% | → |
| 2024-11-04 | Amoroso Michael | President and CEO | Sale+OE | 3,012 | $8.19 | $24,668.28 | -9.5% | → |
| 2024-06-10 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 50 | $11.79 | $589.50 | - | → |
| 2024-06-10 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 93 | $11.79 | $1,096.47 | -1.4% | → |
| 2024-05-02 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 272 | $10.32 | $2,807.04 | -4.6% | → |
| 2024-05-02 | List Alan | Chief Medical Officer | Sale+OE | 290 | $10.32 | $2,992.80 | -6.1% | → |
| 2024-05-02 | Amoroso Michael | President and CEO | Sale+OE | 1,526 | $10.32 | $15,748.32 | -10.0% | → |
| 2024-05-02 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 154 | $10.32 | $1,589.28 | -0.2% | → |
| 2024-04-30 | List Alan | Chief Medical Officer | Sale+OE | 238 | $10.03 | $2,386.43 | -5.9% | → |
| 2024-01-23 | SMITH J. JEFFERSON | Chief Research Officer | Sale+OE | 28,000 | $0.37 | $10,360.00 | -1.4% | → |
| 2024-01-22 | Amoroso Michael | President and CEO | Sale+OE | 137,390 | $0.36 | $49,460.40 | -27.8% | → |
| 2024-01-22 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 21,287 | $0.36 | $7,663.32 | -12.4% | → |
| 2024-01-22 | List Alan | Chief Medical Officer | Sale+OE | 21,526 | $0.36 | $7,749.36 | -18.5% | → |
| 2023-11-03 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 16,023 | $0.40 | $6,409.20 | -12.4% | → |
| 2023-11-03 | Amoroso Michael | President and CEO | Sale+OE | 125,025 | $0.40 | $50,010.00 | -35.5% | → |
| 2023-06-08 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 13,361 | $0.75 | $10,020.75 | -16.3% | → |
| 2023-04-27 | List Alan | Chief Medical Officer | Sale+OE | 7,771 | $0.79 | $6,139.09 | -12.1% | → |
| 2023-03-22 | Amoroso Michael | President and CEO | Sale+OE | 46,999 | $0.82 | $38,539.18 | -40.6% | → |
| 2023-03-17 | Kelly John Alexander | Chief Financial Officer | Buy | 20,000 | $0.86 | $17,200.00 | +8.9% | → |
| 2023-03-06 | List Alan | Chief Medical Officer | Sale+OE | 9,473 | $1.07 | $10,136.11 | -19.9% | → |
| 2023-03-06 | Scimeca Dario | General Counsel and Secretary | Sale+OE | 12,172 | $1.07 | $13,024.04 | -19.6% | → |